DKSH and Kyowa Kirin Partner To transform business In APAC Region

DKSH Business Unit Healthcare, a key player in market expansion services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies, collaborates with Kyowa Kirin Co., Ltd, a global specialty pharmaceutical company from Japan, to support Kyowa Kirin's business transformation in Asia-Pacific.

The partnership includes a deal for commercial rights of Kyowa Kirin's medicines in South Korea, Taiwan, Singapore, Thailand, Malaysia, Hong Kong & Macau SAR, and global products Crysvita® in Singapore, Thailand, Malaysia, Hong Kong & Macau SAR and Poteligeo® in Singapore.

DKSH has been selected by Kyowa Kirin as its strategic partner to implement a full agency alliance business model that provides a complete range of integrated solutions to support sustainable growth for client partners, prioritizing healthcare access to patients. DKSH's extensive knowledge in nephrology, strong distribution channels, and solid commercial skills make this partnership a significant advancement in enhancing patient care and access in the region.

"We are very confident about this new journey with DKSH", stated Abdul Mullick, Ph.D., Chief International Business Officer (CIBO), Kyowa Kirin. "Given DKSH's proven healthcare expertise and commercial strength across Southeast Asia and North Asia, we are convinced we have chosen the right business partner to continue serving our patients, taking care of our employees and making people smile."